LogicMark, Inc. Payments to Develop Software
LogicMark, Inc. (LGMK) reported Payments to Develop Software of $98.97 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToDevelopSoftware · last filed 2026-08-19
- LogicMark, Inc. payments to develop software for the quarter ending 2026-06-30 was $47.93K, a 89.77% decline year-over-year.
- LogicMark, Inc. payments to develop software for the quarter ending 2026-03-31 was $51.03K, a 70.59% decline year-over-year.
- LogicMark, Inc. payments to develop software for the quarter ending 2025-12-31 was $141.93K, a 54.65% decline year-over-year.
- LogicMark, Inc. payments to develop software for the quarter ending 2025-09-30 was $333.42K, a 10.40% increase year-over-year.
- LogicMark, Inc. payments to develop software for fiscal 2025 was $1.12M, a 11.76% increase from fiscal 2024.
- LogicMark, Inc. payments to develop software for fiscal 2024 was $999.71K, a 31.99% increase from fiscal 2023.
- LogicMark, Inc. payments to develop software for fiscal 2023 was $757.40K, a 108.07% increase from fiscal 2022.
- LogicMark, Inc. payments to develop software for fiscal 2022 was $364.02K.
| Period end | Payments to Develop Software 3 month | Payments to Develop Software 6 month | Payments to Develop Software 9 month | Payments to Develop Software 12 month |
|---|---|---|---|---|
| 2026-06-30 | $47.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $98.97K 10-Q · filed 2026-08-19 | $240.90K derived: sum of 3 quarters · filed 2026-08-19 | $574.32K derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $51.03K 10-Q · filed 2026-05-15 | $192.97K derived: sum of 2 quarters · filed 2026-05-15 | $526.39K derived: sum of 3 quarters · filed 2026-05-15 | $994.82K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $141.93K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $475.36K derived: sum of 2 quarters · filed 2026-03-27 | $943.78K derived: sum of 3 quarters · filed 2026-08-19 | $1.12M 10-K · filed 2026-03-27 |
| 2025-09-30 | $333.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $801.85K derived: sum of 2 quarters · filed 2026-08-19 | $975.37K 10-Q · filed 2025-11-13 | $1.29M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $468.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $641.95K 10-Q · filed 2026-08-19 | $954.90K derived: sum of 3 quarters · filed 2026-08-19 | $1.26M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $173.52K 10-Q · filed 2026-05-15 | $486.47K derived: sum of 2 quarters · filed 2026-05-15 | $788.49K derived: sum of 3 quarters · filed 2026-05-15 | $1.04M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $312.95K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $614.97K derived: sum of 2 quarters · filed 2026-03-27 | $867.95K derived: sum of 3 quarters · filed 2026-03-27 | $999.71K 10-K · filed 2026-03-27 |
| 2024-09-30 | $302.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $555.01K derived: sum of 2 quarters · filed 2025-11-13 | $686.76K 10-Q · filed 2025-11-13 | $860.60K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $252.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $384.74K 10-Q · filed 2025-08-13 | $558.57K derived: sum of 3 quarters · filed 2025-08-13 | $1.05M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $131.75K 10-Q · filed 2025-05-15 | $305.59K derived: sum of 2 quarters · filed 2025-05-15 | $799.10K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $173.84K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $667.35K derived: sum of 2 quarters · filed 2025-03-31 | $757.40K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $493.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $583.56K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $90.05K 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $115.58K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $271.04K derived: sum of 2 quarters · filed 2024-04-16 | $364.02K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $155.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $248.44K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $92.98K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |